PEBP1, also named RKIP (Raf kinase inhibitory protein), is well characterized by disrupting rapidly accelerated fibrosarcoma (Raf) and mitogen-activated protein (MEK) interaction via exclusive and competitive binding to either of them, leading to inhibition of signal transmission from Raf to MEK. Here, MAP2K7 is linked to fibrosarcoma.